PepLabo Download

Taste changes (dysgeusia) on GLP-1 medications

Some people find that food tastes flat, metallic or simply wrong after starting a GLP-1 medicine. The product documents call this dysgeusia and several report how often it came up in trials. This article lines up those figures across US, European and Canadian documents, explains what studies of spontaneous reports and one small randomised trial found, separates taste from smell, lists other common causes and marks the taste change that can signal an emergency in diabetes.

Published · Updated · Side effects · Written by the PepLabo editorial team

What the labels and official product information report

Dysgeusia is the medical word for a distorted sense of taste. NIDCD, the US institute for communication disorders, describes it as a foul, salty, rancid or metallic taste that lingers in the mouth [15]. The US labels mention it in short paragraphs or lists outside their main adverse reaction tables [1][3].

  • Even the highest figure means about one extra person in a hundred compared with placebo [1].
  • A post-approval entry comes from voluntary reports from a population of unknown size, so the labels say it cannot give a reliable frequency or prove cause [7].
  • The Canadian Zepbound® patient information lists a change in taste among possible side effects [8]; the US Medication Guides we checked do not mention taste.
  • Rows describe different trials, doses and people. They show that taste changes were reported, not which medicine causes more.
Dysgeusia in GLP-1 product documents (checked 20 October 2026)
Document and trial poolMedicineComparison
Wegovy®, US label, adult weight trials [1]1.7%Placebo 0.5%
Wegovy®, EU product information, section 4.8 [9]Common; mainly during dose increases—
Foundayo™ daily tablet, US label, Trials 1 and 2 [2]0.9%Placebo 0.3%
Zepbound®, US label, Studies 1 and 2 [3]0.4%Placebo 0%
Zepbound®, Canadian monograph, section 8.3 [8]Less common trial reaction, no rate—
Mounjaro®, US label, adult placebo pool [4]0.1%Placebo 0%
Ozempic® injection, US label [5]Above 0.4%, no exact rateNo placebo figure
Ozempic®, EU package leaflet [10]Uncommon (up to 1 in 100)—
Saxenda®, US label [6]Reported, no rate; mostly first 12 weeks—
Rybelsus® and Ozempic® tablets, US label [7]Reports after approval only—

What studies of reports and trials add

Two 2025 analyses used the US Food and Drug Administration’s adverse event reporting system. One, looking at ear, nose and throat problems, found disproportionate reporting of dysgeusia with semaglutide and liraglutide, and of dry mouth and loss of smell with semaglutide [11]. The other, on neurological reports for six GLP-1 medicines, found signals for dysgeusia, taste disorder and distorted smell; across all neurological reports, the median time from starting treatment was 32 days [12]. The neurological analysis states plainly that its findings are associations, not proof of cause, and both depend on who chooses to report.

A small randomised trial points in a different direction. In 30 women with obesity and polycystic ovary syndrome, 16 weeks of weekly semaglutide improved overall scores on a test of recognising sweet, salty, sour and bitter, compared with placebo. Tongue samples showed changes in genes linked to taste signalling, and brain scans showed altered responses to sweet tastes [13]. The trial was single-blinded, short and limited to one group, so it cannot be generalised, but it shows that “taste change” does not always mean worse taste.

Why taste may change

  • Supported by the labels: taste changes cluster early and around dose increases, and often travel with nausea, vomiting or diarrhea [6][9].
  • Supported by the labels, linked by general sources: Zepbound® reports a dry mouth or throat in 1% against 0.1% on placebo [3], and MedlinePlus lists mouth dryness among the causes of impaired taste [14].
  • Proposed but not proven: the semaglutide trial found changes in taste-related gene activity in the tongue and in brain responses to sweetness [13]. Whether similar effects explain the reports of distorted taste is not known.
  • General knowledge: smell problems, colds and sinus infections, heavy smoking, poor oral hygiene, gum inflammation, low vitamin B12 or zinc, and many other medicines can all change taste [14][15].

Taste or smell, and other causes

Much of what we call flavour is really smell. NIDCD explains that a blocked nose from a cold can make food seem bland, and that true loss of taste is rare [15]. If food has lost its flavour rather than turned unpleasant, a smell problem is worth considering.

MedlinePlus lists other causes: flu and other viral infections, sinusitis and nasal polyps, throat infections, injury to the mouth, nose or head, swollen gums, and medicines such as some thyroid medicines, antibiotics and cancer treatments [14]. NIDCD adds dental problems, radiation to the head and neck and some antihistamines [15]. A new toothpaste or mouthwash is also something a clinician may ask about [14].

What may help

No label gives advice for altered taste. NIDCD says good oral hygiene helps keep the sense of taste working, that taste often returns when an infection or allergy settles, and that finding the cause is the main step [15]. MedlinePlus suggests stopping smoking and following the advice your clinician gives, which may include diet changes [14].

NIDCD notes that people who lose taste may add more sugar or salt to make food enjoyable, which matters for anyone with diabetes or high blood pressure [15]. If food tastes so wrong that you are eating much less, the low-appetite article and a dietitian can help. NIDCD is clear that a suspected medicine should be stopped or changed only on a doctor’s advice [15].

Where brand detail and nearby symptoms are covered

Brand pages such as Wegovy® and taste changes, Mounjaro® and taste changes and Saxenda® and taste changes go through each label. Dry mouth and bad breath each have their own article.

Ozempic®, Wegovy®, Rybelsus® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company; Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Novo Nordisk or Eli Lilly and Company.

When to get help

SignWho to contactHow fastSource
In diabetes: a sweet or metallic taste with strong thirst, breathing difficulty or confusion (possible ketoacidosis)Emergency care (911 or local number)EmergencyOzempic® EU package leaflet [10]
Taste changes with vomiting or diarrhea that will not settle, or keeping little fluid downYour prescriberTodayZepbound® label, section 5.3 [3]
A taste problem that does not go away, or comes with other symptomsYour prescriber or GPAt your next appointmentMedlinePlus [14]
A burning feeling in the mouth along with an unpleasant tasteYour doctor or dentistAt your next appointmentNIDCD [15]
Eating much less, or adding a lot of sugar or salt, because food tastes wrongYour prescriber or a dietitianAt your next appointmentNIDCD [15]

Questions

Does tirzepatide change your taste?

It is reported rarely: 0.4% in the Zepbound® weight trials and 0.1% in the Mounjaro® pool, with no cases on placebo in either [3][4].

Is a metallic taste a GLP-1 side effect?

The labels list dysgeusia, the general term, without describing a metallic taste [1][3]. NIDCD includes metallic among its forms [15]. In diabetes, a metallic or sweet taste with strong thirst can signal ketoacidosis and needs urgent care [10].

Do taste changes go away?

No label gives a duration. Saxenda® reports them mainly in the first 12 weeks [6], and the EU Wegovy® information places them mainly in the dose-increase period [9]. A change that lasts is worth reporting [14].

Does semaglutide make sweet food taste different?

In one small trial in 30 women, semaglutide improved taste recognition and changed brain responses to sweet tastes compared with placebo [13]. The study was too small to apply to everyone.

Could it be my sense of smell instead?

Often. NIDCD says most people who think they have lost taste have a smell problem instead [15], and MedlinePlus notes that much of taste is really smell [14].

Should I stop my medicine if food tastes wrong?

No, not on your own. NIDCD advises against stopping any medicine unless your doctor directs it [15]. Your prescriber can look at timing, other medicines and other causes.

Sources

Sources checked on

  1. WEGOVY® (semaglutide) injection and tablets Prescribing Information, Novo Nordisk Revised 06/2026. Section 6.1 (Dysgeusia).
  2. FOUNDAYO™ (orforglipron) Prescribing Information, Eli Lilly and Company Revised 07/2026. Section 6.1.
  3. ZEPBOUND® (tirzepatide) Prescribing Information, Eli Lilly and Company Revised 08/2026. Sections 5.3 and 6.1.
  4. MOUNJARO® (tirzepatide) Prescribing Information, Eli Lilly and Company Revised 08/2026. Section 6.1.
  5. OZEMPIC® (semaglutide) injection Prescribing Information, Novo Nordisk Revised 05/2026. Section 6.1.
  6. SAXENDA® (liraglutide) Prescribing Information, Novo Nordisk Revised 02/2026. Section 6.1.
  7. RYBELSUS® and OZEMPIC® tablets Prescribing Information, Novo Nordisk Revised 1/2026. Section 6.2.
  8. ZEPBOUND® (tirzepatide injection) Product Monograph, Eli Lilly Canada Section 8.3 and patient medication information.
  9. Wegovy® EPAR product information (SmPC and package leaflet), European Medicines Agency Accessed 20-10-2026. Section 4.8, Table 3.
  10. Ozempic® EPAR product information (SmPC and package leaflet), European Medicines Agency Accessed 20-10-2026. Package leaflet sections 2 and 4.
  11. Khan FI, Vazquez SG, Mehdi Z, et al. Otolaryngologic Side Effects of GLP-1 Receptor Agonists. Laryngoscope 2025;135(7):2291–2298 FAERS disproportionality analysis; PMID 39936458.
  12. Chen H, Liu S, Gao S, et al. Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System. Sci Rep 2025;15:18063 FAERS disproportionality analysis, 2005–2024; PMID 40413246.
  13. Jensterle M, Kovac J, Vovk A, et al. Semaglutide and Taste in Women With Obesity and Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Study. J Clin Endocrinol Metab 2025 Single-blinded randomised trial, 30 women, 16 weeks; PMID 40341357.
  14. Taste - impaired, MedlinePlus Medical Encyclopedia U.S. National Library of Medicine.
  15. Taste Disorders, National Institute on Deafness and Other Communication Disorders (NIH)

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.